Los Angeles Capital Management
SRPT icon

Los Angeles Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Los Angeles Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1K Hold
463
– – ﹤0.01% 1953
2025
Q4 		$10.8K Buy
+463
New +$9.76K ﹤0.01% 2053
2021
Q1 		– Sell
-68,539
Closed -$11.7M – 1648
2020
Q4 		$11.7M Sell
68,539
-53,276
-44% -$7.89M 0.05% 258
2020
Q3 		$17.1M Sell
121,815
-7,552
-6% -$1.15M 0.08% 185
2020
Q2 		$20.7M Buy
129,367
+42,523
+49% +$5.79M 0.1% 188
2020
Q1 		$8.49M Buy
+86,844
New +$9.93M 0.05% 265
2019
Q2 		– Sell
-2,180
Closed -$260K – 1416
2019
Q1 		$260K Buy
+2,180
New +$280K ﹤0.01% 1238
2018
Q2 		– Sell
-10,620
Closed -$787K – 1491
2018
Q1 		$787K Buy
+10,620
New +$708K ﹤0.01% 896

Other funds holding SRPT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return